Medlive Technology Co., Ltd.

Medlive Technology Co., Ltd.'s next confirmed earnings release is scheduled for March 29, 2027.

As of December 31, 2025, Medlive Technology Co., Ltd. has 737.03M shares outstanding.

As of December 31, 2025, Medlive Technology Co., Ltd. maintains a current ratio of 19.09, meaning it holds 19.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on September 9, 2026, Medlive Technology Co., Ltd.'s stock has declined approximately 67.27% over the past 52 weeks. The 50-day moving average sits at 0.81, while the 200-day moving average is 1.40.

As of December 31, 2025, Medlive Technology Co., Ltd. holds 452.86M in cash and equivalents against 1.23M in total debt, resulting in a net debt position of -312.46M. Total book value stands at 591.97M, with working capital of 460.30M providing operational flexibility.